Evidence map›Paper›PMID 30513485›Full record

ReviewSocial science & medicine (1982)2019

A framework for conducting economic evaluations alongside natural experiments.

Manuela Deidda, Claudia Geue, Noemi Kreif, Ruth Dundas, Emma McIntosh

Abstract readReview
In one paragraph

Review in Social science & medicine (1982), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. A systematic review of economic evidence for community-based obesity prevention interventions in children.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2023
    Pooled it
  3. A consensus-based checklist for the critical appraisal of cost-of-illness (COI) studies.International journal of technology assessment in health care · 2023
    Guideline
  4. Pooled it
  5. [Economic evaluation in the health sector: The link between economic and health variables].Revista medica del Instituto Mexicano del Seguro Social · 2026
    Review
  6. Social Return on Investment ofBehavioral sciences (Basel, Switzerland) · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Manuela DeiddaHealth Economics & Health Technology Assessment, Institute of Health & Wellbeing, University of Glasgow, 1 Lilybank Gardens, Glasgow, G12 8RZ, United Kingdom. Electronic address: Manuela.deidda@glasgow.ac.uk.
Claudia GeueHealth Economics & Health Technology Assessment, Institute of Health & Wellbeing, University of Glasgow, 1 Lilybank Gardens, Glasgow, G12 8RZ, United Kingdom.
Noemi KreifCentre for Health Economics, University of York, Heslington, York, YO10 5DD, United Kingdom.
Ruth DundasMRC/CSO Social and Public Health Sciences Unit, University of Glasgow, 200 Renfield Street, Glasgow, G2 3QB, United Kingdom.
Emma McIntoshHealth Economics & Health Technology Assessment, Institute of Health & Wellbeing, University of Glasgow, 1 Lilybank Gardens, Glasgow, G12 8RZ, United Kingdom.

Funding

Chief Scientist OfficeDepartment of Health PHR/13/164/10Medical Research Council MC_UU_12017/13Medical Research Council MR/L012332/1Medical Research Council MR/L012332/2
6 · The paper itself

Abstract

Internationally, policy makers are increasingly focussed on reducing the detrimental consequences and rising costs associated with unhealthy diets, inactivity, smoking, alcohol and other risk factors on the health of their populations. This has led to an increase in the demand for evidence-based, cost-effective Population Health Interventions (PHIs) to reverse this trend. Given that research designs such as randomised controlled trials (RCTs) are often not suited to the evaluation of PHIs, Natural Experiments (NEs) are now frequently being used as a design to evaluate such complex, preventive PHIs. However, current guidance for economic evaluation focusses on RCT designs and therefore does not address the specific challenges of NE designs. Using such guidance can lead to sub-optimal design, data collection and analysis for NEs, leading to bias in the estimated effectiveness and cost-effectiveness of the PHI. As a consequence, there is a growing recognition of the need to identify a robust methodological framework for the design and conducting of economic evaluations alongside such NEs. This paper outlines the challenges inherent to the design and conduct of economic evaluations of PHIs alongside NEs, providing a comprehensive framework and outlining a research agenda in this area.

Indexed as

Cost-Benefit AnalysisPopulation HealthResearch DesignBiasHumansChecklistEconomic evaluationGuidanceNatural experimentsPopulation health interventions

Identifiers

PMID30513485
PMCPMC6323352

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.